M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_11579

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_11579 34 0.71 Mlig455_045788

Neo: -

Age: -

 Mlig455_045788 {REF} {Length: 2523} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=39.4]} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1}

Cumulative graph for MligTC455_11579

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 0.926 1.103 1.00000 1.00000
RegionR2 -0.865 1.103 0.88936 1.00000
RegionR3 -0.778 1.103 0.84033 1.00000
RegionR4 1.723 1.103 0.19695 0.47547
RegionR5 0.489 1.103 0.46941 0.83200
RegionR6 -3.029 1.103 1.00000 1.00000
RegionR7 -1.866 1.103 0.99988 1.00000
RegionR8 3.4 1.103 0.11624 0.62928

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -2.227 1.103 0.99986 1.00000
RegenerationR2 3.103 1.103 0.00302 0.08403
RegenerationR3 1.228 1.103 0.53375 0.87419
RegenerationR4 0.856 1.103 0.77762 0.97963
RegenerationR5 -0.66 1.103 0.49444 0.85564
RegenerationR6 3.078 1.103 0.12193 0.42974
RegenerationBL 2.314 1.103 0.14126 0.44816
RegenerationTP -3.211 1.103 1.00000 1.00000


Genes with expression patterns similar to MligTC455_11579

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_11579 34 0.71 Mlig455_045788

Neo: -

Age: -

 3 - - - 1.000 1.000 1.000 Mlig455_045788 {REF} {Length: 2523} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=39.4]} {RNA1509_6409} {RNA1310_984} {RNA815_7594.1}
2. MligTC455_20757 286 5.96 Mlig455_005125, Mlig455_005185

Neo: -

Age: -

 1.879 - - - 0.926 0.953 -

Mlig455_005125 {REF} {Length: 1290} {RNA1310_29676.2} {RNA815_31533}

Mlig455_005185 {REF} {Length: 1357} {RNA1310_29676.1} {RNA815_31533}
3. MligTC455_45205 147 3.06 Mlig455_058679

Neo: Int S/G2/M

Age: -

Region-enriched R2: 3.694/0.00736
Region-enriched R4: 2.642/0.00370

 1.779 - - - 0.963 0.816 - Mlig455_058679 {REF} {Length: 1141} {RNA1509_48085} {RNA1310_40804} {RNA815_27336}
4. MligTC455_41131 40 0.84 Mlig455_042108

Neo: -

Age: -

 1.753 - - - 0.973 0.780 - Mlig455_042108 {REF} {Length: 1899} {Pfam: F5/8 type C domain [PF00754.27, score=36.7]} {Celegans: WBGene00015646, mlt-10, [Score=161, Expect=1e-44]} {RNA1310_54710.3} {RNA815_24559}
5. MligTC455_10953 148 3.08 Mlig455_060864, Mlig455_063528

Neo: -

Age: Up-Down-Down

Region-enriched R2: 4.497/0.01237
Region-enriched R5: 3.064/0.03185

 KCNH7 1.739 - - - 0.971 0.768 -

Mlig455_060864 {REF} {Length: 7144} {Pfam: Ion transport protein [PF00520.33, score=117.5]; Cyclic nucleotide-binding domain [PF00027.31, score=52.7]; Ion channel [PF07885.18, score=45.4]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=777, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=760, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=751, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=776, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=761, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=751, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=712, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=798, Expect=0.0]} {RNA1509_40124} {RNA1310_4074} {RNA815_8044}

Mlig455_063528 {REF} {Length: 734} {NoTransDecoderORF}
6. MligTC455_42391 1050 21.88 Mlig455_010516, Mlig455_061820, Mlig455_061856, Mlig455_061864

Neo: -

Age: Down-Up-Up

 1.734 - - - 0.952 0.782 -

Mlig455_010516 {REF} {Length: 729} {RNA1509_38791} {RNA1310_69853, RNA1509_38791} {RNA1509_38791, RNA815_39199}

Mlig455_061820 {REF} {Length: 705} {RNA1509_38791} {RNA1310_69853} {RNA815_39199}

Mlig455_061856 {REF} {Length: 708} {RNA1509_38791} {RNA1310_69853} {RNA815_39199}

Mlig455_061864 {REF} {Length: 1146} {RNA1509_38791} {RNA1310_69853} {RNA815_39199}
7. MligTC455_19583 95 1.97 Mlig455_010583, Mlig455_010602

Neo: -

Age: -

Region-enriched R2: 6.442/0.00383

 1.728 - - - 0.957 0.771 -

Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135}

Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135}
8. MligTC455_10899 46 0.95 Mlig455_013784, Mlig455_013915

Neo: -

Age: -

 1.72 - - - 0.964 0.756 -

Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307}

Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307}
9. MligTC455_30634 114 2.38 Mlig455_025888

Neo: -

Age: Up-Down-Up

Region-enriched R2: 6.750/0.00140

 1.713 - - - 0.959 0.754 - Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1}
10. MligTC455_16358 1175 24.47 Mlig455_039878

Neo: -

Age: -

Region-specific R2: 4.659

Region-enriched R2: 4.310/0.00000

 1.696 - - - 0.950 0.746 - Mlig455_039878 {REF} {Length: 1188} {RNA1509_60020} {RNA1310_35099.1, RNA1509_60020} {RNA1509_60020, RNA815_1356.1}
11. MligTC455_20154 22 0.45 Mlig455_002425

Neo: -

Age: -

 OTOP2 1.677 - - - 0.955 0.722 - Mlig455_002425 {REF} {Length: 2659} {Pfam: Otopetrin [PF03189.15, score=233.1]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=55.1, Expect=3e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=62.4, Expect=1e-09]} {Dmel: FBgn0259150, CG42265, [Score=197, Expect=2e-52]} {Celegans: WBGene00015035, otpl-1, OToPetrin-Like, [Score=117, Expect=6e-27]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=296, Expect=3e-91]} {RNA1310_52344} {RNA815_48323}
12. MligTC455_40406 59 1.23 Mlig455_062481

Neo: -

Age: -

 CHRNA9 1.673 - - - 0.952 0.721 - Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3}
13. MligTC455_35373 50 1.03 Mlig455_065912, Mlig455_070019

Neo: -

Age: Down-Up-Down

Regeneration-upregulated BL: 7.651

Regeneration-enriched BL: 7.651

 GLRA2 0.988 - - - 0.988 - -

Mlig455_065912 {REF} {Length: 3290} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=121.2]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=327, Expect=1e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=321, Expect=2e-104]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=319, Expect=1e-103]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=325, Expect=4e-106]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=323, Expect=3e-105]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=3e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=2e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=291, Expect=5e-93]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=283, Expect=3e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491}

Mlig455_070019 {REF} {Length: 4890} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=157.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=120.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=326, Expect=2e-106]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=323, Expect=4e-105]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=318, Expect=2e-103]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=325, Expect=5e-106]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=324, Expect=7e-106]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=317, Expect=6e-103]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=313, Expect=1e-101]} {Dmel: FBgn0024963, GluClalpha, [Score=288, Expect=7e-92]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [RH, Score=249, Expect=2e-76]} {Smed: dd_Smed_v6_15331_0_1, dd_Smed_v6_15331_0_1, [Score=284, Expect=2e-90]} {RNA1509_32923} {RNA1310_14629.1} {RNA815_27491}
14. MligTC455_39710 32 0.67 Mlig455_034221

Neo: -

Age: -

 0.98 - - - 0.980 - - Mlig455_034221 {REF} {Length: 1621} {NoTransDecoderORF} {RNA1509_18723} {RNA1310_2938.3} {RNA815_14343.1}
15. MligTC455_44662 76 1.57 Mlig455_038241

Neo: -

Age: logFC(26M/2M)=-0.868

 ANO7 0.978 - - - 0.978 - - Mlig455_038241 {REF} {Length: 3705} {Pfam: Calcium-activated chloride channel [PF04547.14, score=457.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=572, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=561, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=420, Expect=3e-137]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=165, Expect=1e-43]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=659, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650}
16. MligTC455_26463 46 0.95 Mlig455_009434

Neo: -

Age: Down-Down-Up

 CLCA1 0.971 - - - 0.971 - - Mlig455_009434 {REF} {Length: 3958} {Pfam: von Willebrand factor type A domain [PF13519.8, score=57.9]; von Willebrand factor type A domain [PF00092.30, score=42.8]; von Willebrand factor type A domain [PF13768.8, score=41.5]; Calcium-activated chloride channel N terminal [PF08434.13, score=31.1]; VWA domain containing CoxE-like protein [PF05762.16, score=22.1]} {Human: ENSG00000016490, CLCA1, chloride channel accessory 1, [Score=149, Expect=3e-36]; ENSG00000016602, CLCA4, chloride channel accessory 4, [Score=147, Expect=1e-35]} {Mouse: ENSMUSG00000068547, Clca4a, chloride channel accessory 4A, [Score=150, Expect=1e-36]; ENSMUSG00000074195, Clca4b, chloride channel accessory 4B, [Score=148, Expect=7e-36]} {Smed: dd_Smed_v6_968_0_1, dd_Smed_v6_968_0_1, [Score=110, Expect=1e-24]} {RNA1509_49943} {RNA1310_21040.1} {RNA815_1871}
17. MligTC455_43838 100 2.08 Mlig455_027740

Neo: -

Age: -

 SYT9 0.97 - - - 0.970 - - Mlig455_027740 {REF} {Length: 2584} {Pfam: C2 domain [PF00168.32, score=117.5]} {Human: ENSG00000170743, SYT9, synaptotagmin 9, [Score=194, Expect=3e-56]} {Mouse: ENSMUSG00000062542, Syt9, synaptotagmin IX, [Score=194, Expect=4e-56]} {Dmel: FBgn0261090, Sytbeta, Synaptotagmin beta, [RH, Score=188, Expect=2e-53]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_19328_0_1, dd_Smed_v6_19328_0_1, [RH, Score=164, Expect=1e-45]} {RNA1509_57021} {RNA1310_11363} {RNA815_14366}
18. MligTC455_51313 10 0.21 Mlig455_042838, Mlig455_045872

Neo: -

Age: -

 0.969 - - - 0.969 - -

Mlig455_042838 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]}

Mlig455_045872 {REF} {Length: 1317} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=32.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=30.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.6]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=104, Expect=4e-25]}
19. MligTC455_10345 30 0.63 Mlig455_018653, Mlig455_018855

Neo: -

Age: -

 0.968 - - - 0.968 - -

Mlig455_018653 {REF} {Length: 1014}

Mlig455_018855 {REF} {Length: 1036}
20. MligTC455_12847 25 0.51 Mlig455_049599

Neo: -

Age: -

 0.968 - - - 0.968 - - Mlig455_049599 {REF} {Length: 1963} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.4]; Olfactory receptor [PF13853.8, score=24.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.1]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [RH, Score=91.7, Expect=1e-19]} {Smed: dd_Smed_v6_35525_0_1, dd_Smed_v6_35525_0_1, [Score=144, Expect=1e-38]} {RNA1310_85894} {RNA815_45174}
21. MligTC455_27279 104 2.17 Mlig455_052989, Mlig455_053048

Neo: -

Age: Up-Down-Up

 ANK2 0.967 - - - 0.967 - -

Mlig455_052989 {REF} {Length: 4886} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=154.0]; Ankyrin repeat [PF00023.32, score=133.3]; Ankyrin repeats (many copies) [PF13637.8, score=116.0]; Ankyrin repeat [PF13606.8, score=101.5]; Ankyrin repeats (many copies) [PF13857.8, score=84.2]; Mab-21 protein [PF03281.16, score=24.8]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=158, Expect=2e-38]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=159, Expect=1e-38]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=149, Expect=8e-36]} {Smed: dd_Smed_v6_10835_0_2, dd_Smed_v6_10835_0_2, [Score=160, Expect=1e-39]} {RNA1509_49840} {RNA1310_24047} {RNA815_2400.1}

Mlig455_053048 {REF} {Length: 5337} {Pfam: Mab-21 protein [PF03281.16, score=25.9]} {RNA1509_57692} {RNA1310_3556, RNA1509_57692} {RNA1509_57692, RNA815_2305}
22. MligTC455_43650 38 0.8 Mlig455_053802, Mlig455_068539

Neo: -

Age: -

Region-enriched R4: 4.824/0.02628

 0.965 - - - 0.965 - -

Mlig455_053802 {REF} {Length: 1475} {Pfam: Activin types I and II receptor domain [PF01064.25, score=23.1]} {RNA1310_88727}

Mlig455_068539 {REF} {Length: 1648} {Pfam: Activin types I and II receptor domain [PF01064.25, score=21.6]} {RNA1310_88727}
23. MligTC455_23969 70 1.46 Mlig455_013710

Neo: -

Age: -

 TRPA1 0.964 - - - 0.964 - - Mlig455_013710 {REF} {Length: 3941} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=70.6]; Ankyrin repeats (3 copies) [PF12796.9, score=67.5]; Ankyrin repeats (many copies) [PF13857.8, score=56.5]; Ankyrin repeat [PF13606.8, score=47.5]; Ankyrin repeat [PF00023.32, score=43.8]; Ion transport protein [PF00520.33, score=38.7]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=159, Expect=2e-40]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=145, Expect=9e-36]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=184, Expect=4e-49]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=158, Expect=2e-40]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [Score=266, Expect=9e-78]} {RNA1509_46488} {RNA1310_4045.1} {RNA815_14390}
24. MligTC455_05911 41 0.85 Mlig455_059077

Neo: -

Age: -

 0.963 - - - 0.963 - - Mlig455_059077 {REF} {Length: 351} {TRANSSPLICED} {Pfam: Receptor family ligand binding region [PF01094.30, score=66.9]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.7]} {Smed: dd_Smed_v6_21015_0_2, dd_Smed_v6_21015_0_2, [Score=84.0, Expect=2e-17]} {RNA1310_13608.2} {RNA815_15283}
25. MligTC455_17571 66 1.38 Mlig455_055064, Mlig455_064061

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-0.733

 0.963 - - - 0.963 - -

Mlig455_055064 {REF} {Length: 762} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_31425} {RNA1310_38834} {RNA815_18319}

Mlig455_064061 {REF} {Length: 903} {TRANSSPLICED} {RNA1509_31425} {RNA1310_38834} {RNA815_18319}
26. MligTC455_38489 116 2.42 Mlig455_012152, Mlig455_028944

Neo: -

Age: -

 ANK1, ANK3 0.963 - - - 0.963 - -

Mlig455_012152 {REF} {Length: 4233} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=378.4]; Ankyrin repeats (many copies) [PF13637.8, score=260.0]; Ankyrin repeats (many copies) [PF13857.8, score=234.7]; Ankyrin repeat [PF00023.32, score=229.8]; Ankyrin repeat [PF13606.8, score=215.9]} {Human: ENSG00000029534, ANK1, ankyrin 1, [Score=313, Expect=3e-87]; ENSG00000145362, ANK2, ankyrin 2, [Score=298, Expect=2e-82]} {Mouse: ENSMUSG00000031543, Ank1, ankyrin 1, erythroid, [Score=305, Expect=2e-84]; ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=295, Expect=1e-82]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=290, Expect=2e-79]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=298, Expect=1e-83]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=286, Expect=2e-80]} {Smed: dd_Smed_v6_2072_0_30, dd_Smed_v6_2072_0_30, [Score=292, Expect=8e-84]} {RNA1509_29504} {RNA1310_1629, RNA1509_29504} {RNA1509_29504, RNA815_5687}

Mlig455_028944 {REF} {Length: 475} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=35.2]; Ankyrin repeat [PF13606.8, score=32.6]; Ankyrin repeats (many copies) [PF13857.8, score=32.5]; Ankyrin repeat [PF00023.32, score=31.7]; Ankyrin repeats (many copies) [PF13637.8, score=30.3]} {Human: ENSG00000151150, ANK3, ankyrin 3, [Score=49.7, Expect=2e-08]; ENSG00000145362, ANK2, ankyrin 2, [Score=49.3, Expect=2e-08]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=49.7, Expect=1e-08]; ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=49.3, Expect=2e-08]; ENSMUSG00000005251, Ripk4, receptor-interacting serine-threonine kinase 4, [Score=48.1, Expect=4e-08]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=53.9, Expect=3e-10]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=50.8, Expect=3e-09]} {Smed: dd_Smed_v6_2072_0_6, dd_Smed_v6_2072_0_6, [Score=49.7, Expect=6e-09]} {RNA1509_29504} {RNA1310_1629} {RNA815_5687}
27. MligTC455_27799 414 8.62 Mlig455_004285, Mlig455_004370

Neo: -

Age: Down-Up-Down

Region-specific R2: 3.850

Region-enriched R2: 5.047/0.00000

 0.962 - - - 0.962 - -

Mlig455_004285 {REF} {Length: 650} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1}

Mlig455_004370 {REF} {Length: 1653} {RNA1509_56105} {RNA1310_32410} {RNA815_17871.1}
28. MligTC455_13355 49 1.01 Mlig455_019617

Neo: -

Age: -

 0.961 - - - 0.961 - - Mlig455_019617 {REF} {Length: 734} {TRANSSPLICED} {Pfam: Receptor family ligand binding region [PF01094.30, score=66.9]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.7]} {Smed: dd_Smed_v6_21015_0_2, dd_Smed_v6_21015_0_2, [Score=84.0, Expect=2e-17]} {RNA1310_13608.1} {RNA815_15283}
29. MligTC455_07230 29 0.6 Mlig455_050441

Neo: -

Age: -

 0.96 - - - 0.960 - - Mlig455_050441 {REF} {Length: 977} {RNA1310_42253}
30. MligTC455_12183 53 1.11 Mlig455_004166, Mlig455_004190

Neo: -

Age: -

Region-enriched R2: 4.930/0.01881

 0.96 - - - 0.960 - -

Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453}

Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453}
31. MligTC455_16263 109 2.28 Mlig455_023494, Mlig455_049156, Mlig455_049194

Neo: -

Age: -

 0.96 - - - - 0.960 -

Mlig455_023494 {REF} {Length: 1030} {RNA1509_39265} {RNA1310_25708} {RNA815_39755}

Mlig455_049156 {REF} {Length: 3295} {RNA1509_39265} {RNA1310_25708, RNA1509_39265} {RNA1509_39265, RNA815_39755}

Mlig455_049194 {REF} {Length: 946} {NoTransDecoderORF} {RNA1509_39265} {RNA1310_25708} {RNA815_39755}
32. MligTC455_15408 207 4.32 Mlig455_009996, Mlig455_049846, Mlig455_049894

Neo: -

Age: Down-Up-Down

 0.958 - - - 0.958 - -

Mlig455_009996 {REF} {Length: 771} {RNA1310_39325} {RNA815_18022}

Mlig455_049846 {REF} {Length: 775} {RNA1310_39325} {RNA815_18022}

Mlig455_049894 {REF} {Length: 775} {RNA1310_39325} {RNA815_18022}
33. MligTC455_40687 28 0.58 Mlig455_040563, Mlig455_062078

Neo: -

Age: -

 PDE1C 0.958 - - - 0.958 - -

Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402}

Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704}
34. MligTC455_10299 72 1.51 Mlig455_023028, Mlig455_023125, Mlig455_023183

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.617

Region-enriched R2: 4.572/0.04281

 ANGPTL1 0.957 - - - 0.957 - -

Mlig455_023028 {REF} {Length: 2538} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=130.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=8e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=112, Expect=1e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=114, Expect=2e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=112, Expect=9e-28]} {Dmel: FBgn0050280, CG30280, [Score=103, Expect=9e-26]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.8, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}

Mlig455_023125 {REF} {Length: 2398} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=127.5]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=112, Expect=2e-27]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=107, Expect=1e-25]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=107, Expect=7e-26]} {Dmel: FBgn0050280, CG30280, [Score=92.8, Expect=6e-22]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=51.2, Expect=3e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}

Mlig455_023183 {REF} {Length: 2190} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=115, Expect=2e-28]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=110, Expect=9e-27]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=113, Expect=4e-28]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=110, Expect=6e-27]} {Dmel: FBgn0003326, sca, scabrous, [Score=104, Expect=8e-25]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=50.4, Expect=4e-08]} {RNA1509_41017} {RNA1310_41391} {RNA815_23568}
35. MligTC455_39665 112 2.33 Mlig455_023730

Neo: -

Age: -

 EPHA7 0.957 - - - 0.957 - - Mlig455_023730 {REF} {Length: 3591} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=285.8]; Protein kinase domain [PF00069.27, score=130.1]; Ephrin receptor ligand binding domain [PF01404.21, score=107.2]; Fibronectin type III domain [PF00041.23, score=95.6]; Ephrin type-A receptor 2 transmembrane domain [PF14575.8, score=57.6]; SAM domain (Sterile alpha motif) [PF07647.19, score=55.1]; SAM domain (Sterile alpha motif) [PF00536.32, score=50.6]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=25.8]; ABC1 atypical kinase-like domain [PF03109.18, score=20.9]; Tyrosine-protein kinase ephrin type A/B receptor-like [PF07699.15, score=19.2]} {Human: ENSG00000135333, EPHA7, EPH receptor A7, [Score=658, Expect=0.0]; ENSG00000145242, EPHA5, EPH receptor A5, [Score=647, Expect=0.0]; ENSG00000116106, EPHA4, EPH receptor A4, [Score=646, Expect=0.0]} {Mouse: ENSMUSG00000028289, Epha7, Eph receptor A7, [Score=659, Expect=0.0]; ENSMUSG00000026235, Epha4, Eph receptor A4, [Score=651, Expect=0.0]; ENSMUSG00000029245, Epha5, Eph receptor A5, [Score=648, Expect=0.0]} {Dmel: FBgn0025936, Eph, Eph receptor tyrosine kinase, [Score=609, Expect=0.0]} {Celegans: WBGene00006868, vab-1, Ephrin receptor 1, [Score=458, Expect=2e-143]} {Smed: dd_Smed_v6_16928_0_1, dd_Smed_v6_16928_0_1, [Score=552, Expect=7e-180]} {RNA1509_24016} {RNA1310_2298.1} {RNA815_19987}
36. MligTC455_10082 430 8.96 Mlig455_000403, Mlig455_000471

Neo: -

Age: -

Region-enriched R2: 2.917/0.00040

 0.956 - - - 0.956 - -

Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422}

Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422}
37. MligTC455_10083 397 8.27 Mlig455_000410, Mlig455_000477

Neo: -

Age: logFC(26M/2M)=1.533

Region-enriched R2: 3.033/0.00070

 0.956 - - - 0.956 - -

Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422}

Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422}
38. MligTC455_24568 25 0.51 Mlig455_038127

Neo: -

Age: Down-Up-Down

 CACNA2D2 0.954 - - - 0.954 - - Mlig455_038127 {REF} {Length: 4202} {Pfam: von Willebrand factor type A domain [PF13519.8, score=41.5]; von Willebrand factor type A domain [PF00092.30, score=36.2]; von Willebrand factor type A domain [PF13768.8, score=30.8]} {Human: ENSG00000007402, CACNA2D2, calcium voltage-gated channel auxiliary subunit alpha2delta 2, [Score=82.8, Expect=2e-16]; ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=79.3, Expect=3e-15]; ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=79.0, Expect=4e-15]} {Mouse: ENSMUSG00000010066, Cacna2d2, calcium channel, voltage-dependent, alpha 2/delta subunit 2, [Score=82.4, Expect=2e-16]; ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [Score=79.3, Expect=3e-15]} {Celegans: WBGene00007041, tag-180, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=430, Expect=2e-140]} {RNA1509_28096} {RNA1310_2030} {RNA815_1872}
39. MligTC455_12544 8 0.17 Mlig455_036530

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-1.002

Region-enriched R4: 4.244/0.01519

 0.952 - - - 0.952 - - Mlig455_036530 {REF} {Length: 1961} {RNA1310_47776.1} {RNA815_35125}
40. MligTC455_33939 15 0.31 Mlig455_018477

Neo: Int S/G2/M

Age: Up-Down-Down, logFC(26M/2M)=-0.565

 GUCY1B1 0.952 - - - 0.952 - - Mlig455_018477 {REF} {Length: 4178} {Pfam: Heme NO binding associated [PF07701.16, score=239.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=198.0]; Haem-NO-binding [PF07700.17, score=172.7]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=343, Expect=9e-106]} {Mouse: ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=350, Expect=4e-106]; ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=348, Expect=7e-108]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=622, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=530, Expect=2e-176]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=818, Expect=0.0]} {RNA1509_41885} {RNA1310_21359} {RNA815_6599.2}
41. MligTC455_36775 251 5.23 Mlig455_045520

Neo: -

Age: -

Region-enriched R2: 6.301/0.00000
Region-enriched R6: 4.982/0.00001

Regeneration-downregulated R2: -3.720

Regeneration-depleted R2: -3.720

 0.951 - - - 0.951 - - Mlig455_045520 {REF} {Length: 976} {RNA1509_48740} {RNA1310_54738.1} {RNA815_27047}
42. MligTC455_39330 190 3.95 Mlig455_052017

Neo: -

Age: -

 0.951 - - - - 0.951 - Mlig455_052017 {REF} {Length: 2286} {RNA1509_28814} {RNA1310_9674} {RNA815_9245}
43. MligTC455_15429 16 0.34 Mlig455_009074

Neo: -

Age: -

 0.95 - - - - - 0.950 Mlig455_009074 {REF} {Length: 266} {NoTransDecoderORF} {RNA1310_28433} {RNA815_55884}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA